Search results
Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug - ET HealthWorld | Pharma
The Economic Times· 8 hours agoBP Lowering Drug: Azilsartan is indicated for the treatment of hypertension to lower blood pressure...
My experience of the JIO- BP EV charging hub at Marathalli, Bangalore | Team-BHP
Team-BHP· 7 hours agoBHPian mathewanil recently shared this with other enthusiasts.I recently had an opportunity to...
Private hospitals in Pune to test fever patients, expecting mothers for Zika
Hindustan Times· 2 hours agoTill July 4, Pune city has reported seven Zika virus cases, the highest in the state, including two...
Zydus Lifesciences Gets Tentative Approval From USFDA For BP Lowering Drug
Free Press Journal· 9 hours agoZydus Lifesciences on Thursday said it has received tentative approval from the US health regulator to market its generic Azilsartan Medoxomil tablets used to treat high blood pressure. The ...
Assam flood situation deteriorates, 1.65 mn people affected in 29 districts
Business Standard India· 14 hours agoThe flood situation in Assam further deteriorated with over 16.50 lakh population affected in 29...
Mets' Kodai Senga taking things 'one game at a time' after successful first rehab outing
SNY· 19 hours agoAfter successfully getting through his second live BP session this weekend, the Mets determined the...
Cash-rich commodities traders snapping up refineries from Big Oil
Business Standard India· 14 hours agoCommodities traders flush with cash are buying oil refineries that energy majors are increasingly...
Hawkers in Salt Lake Sector V Shift Addresses After Eviction Drive | Kolkata News - Times of India
The Times of India· 20 hours agoKolkata: Hawkers evicted from multiple illegal hawking zones in Salt Lake Sector V following the chief minister’s prod have settled on empty walkways and footpaths outside other offices in the ...
Emcure Pharmaceuticals IPO day 2: GMP, subscription status, review to allotment date. Apply or not?...
Livemint· 15 hours agoEmcure Pharmaceuticals IPO GMP: Shares of the company are available at a premium of ₹333 in the grey...
Nuvama bets on pipe, cautious on wood panel stocks ahead of Q1 FY25 results
Business Standard India· 15 hours agoTile manufacturers are projected to achieve 5-6 per cent year-on-year (Y-o-Y) volume growth with...